Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.
LATEST EVENTS AND PRESENTATIONS
Latest financial results
Latest annual filing
For Fiscal Year Ending Mar 31, 2023
320 W 37th Street
New York, NY 10018
Chau Cheng, Ph.D., M.B.A.
Continental Stock Transfer & Trust Company, LLC
1 State Street
New York, NY 10004